Cancer treatment of the central nervous system has contributed positively to long-term disease-free survival from childhood cancers such as acute leukemia and medulloblastoma. However, intrathecal chemotherapy and whole brain radiation are associated with acute, subacute, and delayed toxicities. The purpose of this review article is to summarize what is known about critical events in prenatal and postnatal brain development; the pathophysiology of radiation and chemotherapy neurotoxicity and clinical manifestations and risk factors for acute, subacute, and delayed toxicities. The importance of long-term follow-up and for multidisciplinary interventions that focus on prevention as well as management of identified problems are addressed.
Get full access to this article
View all access options for this article.
References
1.
Bleyer A.: The impact of childhood cancer on the United States and the world. CA Cancer J Clin40:355-367, 1990
2.
Hammond D.: Historical Overview of Childhood Cancer. Plenary Session: Workshop on Quality of Life in Children's Cancer: Implications for Practice and Research. Atlanta, GA, January 1995
3.
Volpe J.: Neurology of the Newborn. Philadelphia, PA, Saunders, 1987
4.
Holmes G.: Morphological and physiological maturation of the brain in the neonate and young child. J Clin Neurophysiol, 3:209-238, 1986
5.
Lund R.: Development and Plasticity of the Brain: An Introduction. New York, NY, Oxford Press, 1978
6.
Berger B.: Neurologic Aspects of Pediatrics. Boston, MA,Butterworth-Heinemann, 1992
7.
Gilbert M., Kegan A.: Radiation Damage to the Central Nervous System. New York, NY, Raven Press, 1980
8.
Ch'ien F., Aur R., Stanger S., et al: Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol8:273-277, 1980
9.
Bleyer WA: Neurologic sequelae of methotrexate and ionizing radiation: A new classification . Cancer Treatment, 65:89-98, 1981
10.
Packer R., Meadows A., Rorke L., et al: Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol15:241-253, 1987
11.
Price R., Birdwell D.: The central nervous system in childhood leukemia: III. Mineralizing microangiopathy and dystrophic calcification. Cancer42:717-728, 1978
12.
Price R., Jamieson P.: The central nervous system in childhood leukemia: II. Subacute leukoencephalopathy . Cancer35:306-318, 1975
13.
Allen J., Rosen G., Mehta B.: Leukoencephalopathy following high dose IV methotrexate with leucovorin rescue . Cancer Treat Rep64:1261-1274, 1980
14.
Pratt R., Green A., Horowitz M., et al: Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/MESNAJ Clin Oncol4:1253-1261, 1986
15.
Shapiro A., Clarke S., Christian J., et al: Thrombosis in children receiving L-Asparaginase. Determining patients at risk. Am J Pediatr Hematol Oncol15:400-405, 1993
16.
Butler R., Hill J., Steinherz P., et al: Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol12:2621-2629, 1994
17.
Brown R., Madan-Swain A.: Cognitive, neuropsychological and academic sequelae in children with leukemia . J of Learning Disabilities26:74-9D, 1993
18.
Ochs J., Mulhern R., Fairclough D., et al: Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol9:145-151, 1991
19.
Mulhern R., Wasserman A., Fairclough D.; et al: Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial radiation. J Clin Oncol6:315-320, 1988
20.
Schwartz C., Hobbie W., Constine L., et al: Survivors of Childhood Cancer. Assessment and Management. St. Louis, MO, Mosby, 1994
21.
Elliott A., Oakhill A., Goodman S.: Cataracts in childhood leukaemia. Br J Opthalmol69:459-461, 1985
22.
Grant W.: Toxicology of the Eye. Springfield, IL, Charles C Thomas, 1986
23.
Walker D., Pillow J. Waters K, et al: Enhanced Cisplatinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial radiation. Med Pediatr Oncol17:48-52, 1989
24.
Schriock E. , Schell M., Carter M., et al: Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol9:400-405, 1991
25.
Shalet S., Clayton P., Price D.: Growth and pituitary function in children treated for brain tumors or acute lymphoblastic leukemia. Horm Res30:53-61, 1988
26.
Kingma A., Mooyaart E., Kamps WA, et al: Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol Oncol15:231-238, 1993
27.
Riccardi R. , Bowers P., Di Chiro G, et al: Abnormal computerized tomography brain scans in children with acute lymphoblastic leukaemia: Serial long-term follow-up. J Clin Oncol3:12-18, 1985
28.
Parsons L., Crosby L., Jones P., et al: Neurotoxic effects of intrathecal chemotherapy (ITT/CTX) as measured by power spectral analysis (PSA) of EEG sleep cycles. Abstract presented at the Neurotrauma Society, Miami FL, October 1994
29.
Moore B., Copeland D., Ried H., et al: Neurophysiological basis of cognitive deficits in long-term survivors of childhood cancer. Arch Neurol49:809-817, 1992
30.
Mahoney D., Fernbach D., Glaze D., et al: Elevated myelin basic protein level in the cerebral spinal fluid of patients with acute lymphoblastic leukemia. J Clin Oncol2:58-61, 1984
31.
Moore I., Kramer JH, Wara W., et al: Alterations in cognitive function and normal tissue damage following CNS therapy in children. Monograph of the First American Cancer Society National Conference on Nursing Research, 27-37, 1991
32.
Mollova N., Moore I., Hutter J., et al: Characterization of human cerebrospinal fluid (CSF) phospholipids by Fast Atom-Bombardment Mass Spectrometry (FABMS). Proceeding from the 41 st American Society ofMass Spectrometry, San Francisco, CA, September 1993
33.
Davison AN, Dobbing J.The developing brain, In: Davison A, Dobbing, J (eds); Applied Neurochemistry. Philadelphia, PA, FA Davis, 1968 , pp 253-312
34.
Kramer J., Moore I.: Age at time of treatment effect on mnemestic functioning following CNS irradiation and intrathecal methotrexate. J Clin Exp. Neuropsychol7:627, 1985
35.
Copeland DR , Fletcher J., Pfefferbaum-Levine B., et al: Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics75:745-753, 1985, '
36.
Jannoun L.: Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukemia?Arch Dis Child58:953-958, 1983
37.
Silber J., Radcliffe J., Peckman V., et al: Whole-brain irradiation and decline in intelligence: The influence of dose and age on IQ score. J Clin Oncol10:1390-1396, 1992 38. Haupt R., Fears T., Robinson L., et al: Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA272:1427-1432, 1994
38.
Blatt J., Bercu B., Gillin C., et al: Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr104:182-187, 1994
39.
Brauner R., Czernichow P., Rappaport R.: Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr108: 332, 1986
40.
Meadows A., Massari D., Fergusson J., et al: Declines in IQ scores and cognitive dysfunctions in children with acute lymphoblastic leukemia treated with cranial irradiation. Lancet2:1015-1018; 1981
41.
Clayton P., Shalet S.: Dose dependency of time of onset of radiation-induced growth hormone deficiency . J Pediatr118:226-228, 1991
42.
Moore I., Kramer JH, Wara W., et al: Cognitive function 44. Glauser T, Packer R: Cognitive deficits in long-term survivors of childhood brain tumors. Child's Nerv Syst7:2-12, 1991
43.
Mulhern R., Fairclough D., Ochs J.: A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy or no cranial irradiation. J Clin Oncol9:1348-1356, 1991
44.
Waber D., Gioia G., Paccia J., et al: Sex differences in cognitive processing in children treated with CNS prophylaxis for acute lymphoblastic leukemia. J Ped Psychol15: 105-122, 1990
45.
Waber D., Tarbell N., Kahn C., et al: The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol.10: 810-817, 1992
46.
Robison L., Meadows A., Nesbit M., et al: Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol6:115-121, 1984
47.
Waber D., Urion D., Tarbell N., et al: late effects of central nervous system treatment of acute lymphoblastic leukemia are sex-dependent. Dev Med Child Neurol32:238-248, 1990
48.
VanEys J: Living beyond cure: Transcending survival. Am J Pediatr Hematol Oncol9:114.118, 1987
